ARYX OTC
ARYx Therapeutics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +25.0%
5Y: -72.2%
$0.00
Last traded 2026-08-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-18M
Net Income
+54.7% YoY
$-20M
Free Cash Flow
+49.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE619.3%
ROA-145.1%
ROIC-810.2%
Valuation
P/E-0.0
P/B-0.0
EV/EBITDA-1.4
Leverage
Debt/Equity-1.59
Current Ratio0.47
Interest Cov.-9.9x
Quality Scores
Piotroski F1/9
Altman Z-56.29
Beneish M0.00